Atractylodes japonica Koidzumi inhibits the production of proinflammatory cytokines through inhibition of the NF-κB/IκB signal pathway in HMC-1 human mast cells
- 1 June 2010
- journal article
- research article
- Published by Springer Nature in Archives of Pharmacal Research
- Vol. 33 (6) , 843-851
Abstract
The rhizome of Atractylodes japonica Koidzumi (AJK) has been used in traditional medicine for treatment of arthritis, bronchitis and respiratory infectious disease, whereas its effects on inflammatory reactions have not been unknown recently. In this study, the effects of AJK on allergic inflammation and its signaling were investigated in the induced human mast cells and animal model. This study showed that ethanol extract of AJK interestingly suppressed the production and mRNA expression of TNF-α, IL-6 and IL-8, as important inflammatory cytokines. Furthermore, AJK inhibited the nuclear translocation of nuclear factor (NF)-κB through inhibition of the phosphorylation of IB-κ, which was additionally elucidated by NF-κB promoter-mediated luciferase activity. In addition, the phosphorylation of ERK was increased in pretreatment with AJK, whereas there was no change in JNK and p38 MAPK. However, AJK showed no effects on anti-DNP IgE-mediated in vivo PCA reaction and histamine release, as key events of mast cell-mediated immediate allergic reactions. These results suggest that AJK might be involved in not early-phase but transition to late-phase reactions of allergic inflammation and could modulate through other signal pathways. Taken together, AJK could be used as a treatment for mast cell mediated late-phase/chronic allergic inflammatory reactions.Keywords
This publication has 29 references indexed in Scilit:
- The development of allergic inflammationNature, 2008
- Integrated signalling pathways for mast-cell activationNature Reviews Immunology, 2006
- Molecular mechanisms for the release of chemokines from human leukemic mast cell line (HMC)‐1 cells activated by SCF and TNF‐α: roles of ERK, p38 MAPK, and NF‐κBAllergy, 2006
- TNF-α induces the late-phase airway hyperresponsiveness and airway inflammation through cytosolic phospholipase A2 activationJournal of Allergy and Clinical Immunology, 2005
- Platelet-activating Factor–mediated NF-κB Dependency of a Late Anaphylactic ReactionJournal of Experimental Medicine, 2003
- Phosphorylation Meets Ubiquitination: The Control of NF-κB ActivityAnnual Review of Immunology, 2000
- Sulindac Inhibits Activation of the NF-κB PathwayJournal of Biological Chemistry, 1999
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Passive cutaneous anaphylaxis in mouse skin is associated with local accumulation of interleukin-6 mRNA and immunoreactive interleukin-6 proteinJournal of Allergy and Clinical Immunology, 1992
- Production of passive cutaneous anaphylaxis (PCA) and reversed PCA by rat IgE antibody in the mouseCellular and Molecular Life Sciences, 1988